Scientific Sources
Below are peer-reviewed studies and authoritative references related to tadalafil and PDE-5 inhibition:
*Actual vial appearance, contents, and dosage may vary and is based on your prescription.
Tadalafil has been extensively studied for its ability to support erectile function by enhancing nitric oxide–mediated vasodilation in penile tissue.
https://pubmed.ncbi.nlm.nih.gov/12825196/
Tadalafil is known for its longer half-life compared to other PDE-5 inhibitors, allowing for extended physiologic activity under provider guidance.
https://pubmed.ncbi.nlm.nih.gov/15342352/
Due to its pharmacokinetic profile, tadalafil has been studied for flexibility in timing relative to sexual activity.
https://pubmed.ncbi.nlm.nih.gov/15509101/
Tadalafil has also been studied for effects related to benign prostatic hyperplasia (BPH) and lower urinary tract symptoms in adult men.
https://pubmed.ncbi.nlm.nih.gov/21130540/
Sublingual administration bypasses first-pass gastrointestinal metabolism, which may be preferred by some individuals. Clinical outcomes vary.
https://pubmed.ncbi.nlm.nih.gov/26140940/
Tadalafil sublingual is prescribed by licensed healthcare providers based on an individual clinical evaluation and medical eligibility. Compounded sublingual formulations are not FDA-approved, and their safety and effectiveness have not been independently evaluated by the FDA.
This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational purposes only and does not constitute medical advice. All care and prescriptions are provided solely at the discretion of a licensed healthcare provider following an individual evaluation.
Below are peer-reviewed studies and authoritative references related to tadalafil and PDE-5 inhibition:
Hear from individuals who chose a more guided, informed approach to their wellness journey.
Quick answers to common questions, designed to help you feel clear and confident as you explore Celara Med.
The active ingredient (tadalafil) is the same. This formulation is a mango-flavored sublingual, not a swallowed tablet. Absorption route and dosing guidance may differ.
The tablet or troche is placed under the tongue and allowed to dissolve fully. Do not chew or swallow unless directed by your provider.
Tadalafil has a longer half-life than many other PDE-5 inhibitors, and effects may persist for up to 36 hours in some individuals.
https://pubmed.ncbi.nlm.nih.gov/15342352/
Adult men seeking support for erectile function or lower urinary tract symptoms may be evaluated by a licensed healthcare provider. Eligibility is determined through individual clinical review.
Possible side effects include headache, flushing, nasal congestion, indigestion, back pain, or dizziness. Side effects vary by individual and should be discussed with a provider.
In some cases, a provider may approve tadalafil alongside other sexual-health or wellness therapies, depending on individual needs and medical history.
Tadalafil sublingual through Celara Med is available in 48 states, excluding Alabama and Mississippi, subject to provider licensure and state regulations.
Yes. Tadalafil sublingual is offered within a structured care plan designed to support appropriate use, monitoring, and clinical oversight.